![System.Func`1[System.String]](/siteassets/images/z-mckesson-logosicons/health-systems2.png)
Answering these questions can help differentiate transactional vendor relationships from strategic partnerships that add value.
Are You Forfeiting Revenue by Underutilizing Your Outpatient Pharmacy?
An underutilized outpatient retail pharmacy may be responsible for revenue left on the table.
By
Date
February 22, 2024
Read time: 2 minutes
The increasing cost pressures on health systems have pushed many to look beyond traditional streams of revenue in order to remain profitable and continue providing a higher standard of care. In recent years, the outpatient pharmacy has emerged as a worthwhile investment for its ability to capture revenue that may otherwise have been missed. Along with discharge prescriptions, the integrated outpatient pharmacy can bring in would-be lost dollars through:
Supporting ambulatory services
This may include dispensing medications for home infusion therapies in order to retain a larger portion of the market – with the home infusion market projected to reach $20.6 billion by 2027.
Specialty medications
Specialty pharmacy may bring in as much as 10% of a health system’s revenue alone.
340B savings
According to the Health Resources and Services Administration (HRSA), enrolled hospitals and covered entities can achieve an average of 25- 50% in savings on pharmaceutical purchases through 340B.
If you feel that your outpatient pharmacy may not be operating at its full potential, McKesson can help.
Find out what other risks you may encounter with an underutilized outpatient pharmacy and learn what solutions McKesson Health Systems has available to help you achieve more by downloading our recent eBook, 3 Costly Risks of Underutilizing Your Outpatient Retail Pharmacy.
To learn more about how McKesson can help you improve the performance of your outpatient pharmacy, you can also contact our McKesson Health Systems experts today.
Related Stories
The most downloaded content by health system pharmacy leaders in October 2025.
Take another opportunity to recognize and celebrate the impactful work of pharmacists as October comes to a close.
McKesson’s Intrafusion expert discusses the measurable impacts of a successful infusion service line in health systems.
Connect with our experts and industry leaders to uncover strategies to help you achieve more.
Join us in taking this opportunity to celebrate the contributions of pharmacy technicians, whose training and professionalism support positive outcomes.
McKesson leaders attending a C-Suite dialogue on leveraging ambulatory pharmacy settings.
Explore the value a strategic partnership can bring in helping take your health system pharmacy further to achieve more.
Use this comprehensive library of resources to find important information on what’s changing with 340B and IRA, when, and why it may matter for your health system pharmacy.
Hear part two of LogiPharma’s interview with McKesson Health Systems President Ammie McAsey.